Testing effectiveness (Phase 2)Study completedNCT00695305
What this trial is testing
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
Who this might be right for
Atherosclerosis
GlaxoSmithKline 83
Showing 20 of 204 results